Loading
Dan Watkins

Dan Watkins

CEO, Pelagos Pharmaceuticals, Inc.
United States
Dan is CEO of Pelagos Pharma and a Co-Founder and Venture Partner at Mercury Fund ($600M AUM). He is also Director and Co-Founder at OmniScience, a company providing AI solutions to life sciences companies for research and clinical trials. Dan was Director and founding CEO of Courier Therapeutics (acquired, pre-clinic, for over $500M in cash and milestone payments). Dan has been an investor and director of numerous companies in life sciences and AI/ML differentiated businesses including companies include Resonant Therapeutics, Swift Biosciences (acquired by Danaher), Benson Hill (NYSE: BHIL), Confluence Life Sciences (acquired by ACRS), Dnatrix, Avenu Medical (acquired by Medtronic), and Asky Therapeutics (stealth).
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS